Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.

Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling A, Eisenhofer G, Adams KT, Pacak K.

J Nucl Med. 2007 Oct;48(10):1599-606.

2.

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.

J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054.

PMID:
19622618
3.

Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.

Rischke HC, Benz MR, Wild D, Mix M, Dumont RA, Campbell D, Seufert J, Wiech T, Rössler J, Weber WA, Neumann HP.

J Nucl Med. 2012 Sep;53(9):1352-8. doi: 10.2967/jnumed.111.101303.

4.

Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, Eisenhofer G, Martiniova L, Adams KT, Pacak K.

J Clin Endocrinol Metab. 2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248.

5.

Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?

Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I.

Clin Nucl Med. 2012 Feb;37(2):e24-9. doi: 10.1097/RLU.0b013e318238f550.

PMID:
22228360
6.

(18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.

Magnaldi S, Mayerhoefer ME, Khameneh A, Schuetz M, Javor D, Mitterhauser M, Dudczak R, Hacker M, Karanikas G.

Anticancer Res. 2014 Feb;34(2):791-5.

PMID:
24511014
7.

A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma.

Kroiss A, Putzer D, Frech A, Decristoforo C, Uprimny C, Gasser RW, Shulkin BL, Url C, Widmann G, Prommegger R, Sprinzl GM, Fraedrich G, Virgolini IJ.

Eur J Nucl Med Mol Imaging. 2013 Dec;40(12):1800-8. doi: 10.1007/s00259-013-2548-y.

PMID:
24072345
8.

6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10. doi: 10.1210/jc.2009-2352.

PMID:
20371665
9.

Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.

Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K.

J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi: 10.1093/jnci/djs188.

10.

18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.

Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW.

J Nucl Med. 2009 Apr;50(4):513-9. doi: 10.2967/jnumed.108.058396.

11.

Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

Martiniova L, Cleary S, Lai EW, Kiesewetter DO, Seidel J, Dawson LF, Phillips JK, Thomasson D, Chen X, Eisenhofer G, Powers JF, Kvetnansky R, Pacak K.

Nucl Med Biol. 2012 Feb;39(2):215-26. doi: 10.1016/j.nucmedbio.2011.07.007.

12.

Role of (18) F-FDOPA PET/CT imaging in endocrinology.

Santhanam P, Taïeb D.

Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98. doi: 10.1111/cen.12566. Review.

PMID:
25056984
13.

Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.

Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.

Nucl Med Commun. 2011 Jul;32(7):575-82. doi: 10.1097/MNM.0b013e328345a340.

PMID:
21471850
14.

18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.

Blanchet EM, Taieb D, Millo C, Martucci V, Chen CC, Merino M, Herscovitch P, Pacak K.

J Nucl Med. 2015 Dec;56(12):1849-54. doi: 10.2967/jnumed.115.159061.

15.

Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.

Bacca A, Chiacchio S, Zampa V, Carrara D, Duce V, Congregati C, Simi P, Taddei S, Materazzi G, Volterrani D, Mariani G, Bernini G.

Clin Nucl Med. 2014 Jan;39(1):14-20. doi: 10.1097/RLU.0000000000000242.

PMID:
24300347
16.

18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.

Marzola MC, Chondrogiannis S, Grassetto G, Rampin L, Maffione AM, Ferretti A, Opocher G, Schiavi F, Colletti PM, Rubello D.

Clin Nucl Med. 2014 Jan;39(1):e53-8. doi: 10.1097/RLU.0b013e31829aface.

PMID:
23856824
17.

Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions.

Gabriel S, Blanchet EM, Sebag F, Chen CC, Fakhry N, Deveze A, Barlier A, Morange I, Pacak K, Taïeb D.

Clin Endocrinol (Oxf). 2013 Aug;79(2):170-7. doi: 10.1111/cen.12126.

18.

Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.

Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, Glatting G, Buck AK, Solbach C, Neumaier B, Reske SN, Mottaghy FM.

Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):484-93. doi: 10.1007/s00259-009-1294-7.

PMID:
19862519
19.

Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome.

Levine DS, Metzger DL, Nadel HR, Oviedo A, Adam MJ, Skarsgard E.

Pediatr Radiol. 2011 Oct;41(10):1321-5. doi: 10.1007/s00247-011-2109-0.

PMID:
21567141
20.

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP.

Radiology. 2002 Feb;222(2):507-12.

PMID:
11818620

Supplemental Content

Support Center